Ultrathin-layered carbon intercalated MoS2 hollow nanospheres integrated with gold nanoparticles for photoelectrochemical immunosensing of squamous cell carcinoma antigen
[Display omitted] •Ultrathin-layered carbon intercalated MoS2 hollow nanospheres were prepared.•Gold nanoparticles were integrated onto C/MoS2 surface by in-situ reduction.•Immunosensor for SCCA was fabricated using AuNPs/C/MoS2 as photoactive element.•High photoelectrochemical sensing performances...
Gespeichert in:
Veröffentlicht in: | Sensors and actuators. B, Chemical Chemical, 2019-10, Vol.297, p.126716, Article 126716 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [Display omitted]
•Ultrathin-layered carbon intercalated MoS2 hollow nanospheres were prepared.•Gold nanoparticles were integrated onto C/MoS2 surface by in-situ reduction.•Immunosensor for SCCA was fabricated using AuNPs/C/MoS2 as photoactive element.•High photoelectrochemical sensing performances of AuNPs/C/MoS2 based immunosensor were demonstrated.
Ultrathin-layered carbon intercalated MoS2 hollow nanospheres (C/MoS2) were prepared with a hydrothermal method combined with high-temperature annealing using cetyltrimethylammonium bromide (CTAB) as the morphological control agent and ammonium molybdate as the molybdenum source. The ultrathin-layered C/MoS2, possessing a direct band-gap of ˜1.8 eV, can promote the visible light absorption and the charge-hole separation ideal for photoelectrochemical (PEC) sensing. Then, the gold nanoparticles (AuNPs) were integrated onto the C/MoS2 surface by in-situ reduction of chloroauric acid without adding any reductant to produce AuNPs/C/MoS2 nanocomposites. Subsequently, AuNPs/C/MoS2 nanocomposites and SCCA antibody (anti-SCCA) were sequentially modified on a glassy carbon electrode (GCE) surface to prepare a PEC immunosensing platform which was denoted as anti-SCCA(BSA)/AuNPs/C/MoS2/GCE. Under optimized conditions, the PEC immunosensor shows a broad linear range from 0.005 ng mL−1 to 8 ng mL−1 and a low detection limit of 1.8 pg mL−1 for determining SCCA. For the assay of SCCA in clinical serum samples, the results obtained from the PEC immunosensor are comparable to the generally accepted ELISA method from a commercial immunoassay kit. |
---|---|
ISSN: | 0925-4005 1873-3077 |
DOI: | 10.1016/j.snb.2019.126716 |